In the subsequent sections, we will discuss the tumor-specific expression of PRL3 in various cancer types, its central role in regulating cellular functions and signaling pathways in cancer, as well as therapeutic targeting of PRL3 via unconventional antibody-based immunotherapy. The gene discussed is PTP4A3; the disease is neoplasm.